Health Trials

Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD

ConditionChronic Graft-versus-host Disease
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
AgeUp to 65
SponsorNavy General Hospital, Beijing

About this trial

This study suggested that hydrogen has a potential as an effective and safe therapeutic agent on cGVHD.

Eligibility criteria

Qualifiers

Written informed consent

Male

not pregnant female

patients <65 years old

Disqualifiers

Patients with stable disease, not well controlled by the current treatment

Pregnancy

HIV positive

Severe liver or renal impairment: serum creatinine >2.5 mg/dl; serum bilirubin>2.5 mg/dl (without evidence of hepatic cGVHD)

Trial design

Treatments tested in this trial

  • Hydrogen

Treatment groups

21 Participants
are divided into 1 treatment group

Sponsors and collaborators

Navy General Hospital, Beijing

Lead sponsor

Source ClinicalTrials.gov